Chikungunya News and Research

RSS

Europe has a new mosquito problem, but it may not be the one you think

A scoping review of 91 studies, combined with a workshop involving 41 experts from six European countries, mapped the spread, biology, surveillance challenges, and potential disease relevance of the invasive mosquito Aedes koreicus. The researchers identified major gaps in species identification, vector competence, ecology, genetics, and long-term surveillance that must be addressed as the cold-tolerant mosquito expands across Europe.

2 Sep 2026

New portable strip test accurately detects mosquito-borne viruses

A research team has developed a multisite bridging-mediated lateral flow immunoassay (mbLFIA) that enables highly sensitive, portable detection of mosquito-borne viruses, using Chikungunya virus (CHIKV) as a model target.

17 Jul 2026

Review highlights traditional Chinese medicine for Chikungunya fever management

Chikungunya fever, caused by Chikungunya virus (CHIKV), has re‑emerged as a major global health threat. The 2025 outbreak in Guangdong, China – the largest local epidemic ever recorded – marks a critical epidemiological turning point.

9 Jul 2026

Oropouche virus infected millions more than official data shows

The recent Oropouche virus outbreak in 2023 drew attention in Brazil and other Latin American countries not only because of its scale – with more than 30,000 cases recorded nationwide – but also because of the first confirmed death in the country caused by the disease and its rapid spread to all states, extending beyond the Amazon region.

18 Jun 2026

New project launches to advance chikungunya vaccine in Africa

Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.

8 Jun 2026

Climate change could expand chikungunya into temperate regions worldwide

Chikungunya ('to become contorted' in the Kimakonde language, named after the characteristic joint ache) is classified as one of the neglected tropical diseases by the World Health Organization.

27 May 2026

New vaccine approach targets broad protection against arenavirus infections

Scientists at La Jolla Institute for Immunology (LJI) have discovered that combining key vaccine ingredients could give the body the tools it needs to fight the entire family of arenaviruses with a single vaccine.

21 May 2026

Climate change drives emerging vector-borne diseases in Canada

Climate change is affecting the local ecology in Canada, contributing to emerging tick- and mosquito-borne diseases and infections in humans, argue authors of a commentary published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.260668.

19 May 2026

African health expert: genomic sequencing enables near real-time pathogen detection

Advanced genomic sequencing techniques, like mNGS, are essential for accurate pathogen detection, crucial for effective outbreak response and patient care.

From BGI Genomics 15 Apr 2026

Griffith researchers on the cusp of new vaccine to prevent chikungunya

Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue.

6 Feb 2026

Orchestrating a global response to the mosquito threat

Mosquitoes are more than just a summer nuisance; they pose a significant global health challenge, killing over 700,000 people every year. Mosquito-borne diseases such as dengue, Zika, and chikungunya were once considered distant threats, but climate change and rapid urbanisation are enabling mosquitoes to spread to new areas, including parts of Europe.

20 Jan 2026

Bat-borne virus linked to unexplained illnesses in Bangladesh

Infectious disease researchers have identified Pteropine orthoreoviruses (PRVs), a group of newly emergent bat-borne viruses, as the culprit for previously unexplained illness in five Bangladeshi patients, one of whom eventually died with unexplained illness.

5 Jan 2026

Single-dose dengue vaccine will benefit populations in hard-to-reach regions

A world-first single-dose vaccine against the dengue virus, manufactured and approved for use in Brazil, will especially benefit populations in hard-to-reach regions of the country such as the Amazon, say disease specialists.

4 Dec 2025

Common viruses sharply raise heart attack and stroke risk, major global review shows

In the largest synthesis to date, researchers reviewed 155 studies linking viral infections, including influenza, SARS-CoV-2, HIV, hepatitis C, and shingles, to increased risks of coronary heart disease, stroke, and heart failure. The findings highlight viral infection prevention and vaccination as underappreciated strategies for cardiovascular protection.

30 Oct 2025

Global Virus Network announces the addition of three new Centers of Excellence

The Global Virus Network (GVN), a coalition of leading medical virologists representing 80+ Centers of Excellence and Affiliates in 40+ countries, today announced the addition of three new Centers of Excellence: the USF Health Institute for Translational Virology and Innovation at the University of South Florida (USF) in Tampa, Florida, USA, the Department of Microbiology, Immunology and Parasitology at the Federal University of São Paulo (UNIFESP) in Brazil, and the Pathogen Research Centre (PaRC) at Western University in Canada.

30 Oct 2025

Global study maps how trade and travel fuel the worldwide spread of disease-carrying mosquitoes

Researchers compiled the first global database tracing how, when, and where non-native mosquito species that transmit human diseases have spread and established. The study reveals accelerating introductions since 1950, driven by trade, transport, and socio-environmental factors, highlighting actionable hotspots for global surveillance.

23 Oct 2025

Understanding the impact of chikungunya on children

Chikungunya is a vector-borne disease that affects both adults and children. While global efforts are ongoing to tackle chikungunya in adults, progress in addressing pediatric chikungunya remains inadequate.

10 Oct 2025

Large-scale analysis offers insights into sporadic nature of chikungunya virus outbreaks

The symptoms come on quickly - acute fever, followed by debilitating joint pain that can last for months. Though rarely fatal, the chikungunya virus, a mosquito-borne illness, can be particularly severe for high-risk individuals, including newborns and older adults.

6 Oct 2025

Genomic studies reveal human influence on mosquito evolution and disease spread

Two of the world's deadliest mosquito vectors – Aedes aegypti and Anopheles funestus – have evolved, spread, and adapted in ways that complicate global disease control, two studies show.

18 Sep 2025

Climate activists cite health hazards in bid to stop Trump from ‘unleashing’ fossil fuels

In 2023, a group of 16 young Montanans won a much-heralded climate change case that said the state had deprived them of a "clean and healthful environment," a right enshrined in Montana's constitution.

11 Sep 2025